Daichao Xu

3.4k total citations · 1 hit paper
33 papers, 1.9k citations indexed

About

Daichao Xu is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Daichao Xu has authored 33 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 10 papers in Immunology and 8 papers in Epidemiology. Recurrent topics in Daichao Xu's work include Cell death mechanisms and regulation (9 papers), Ubiquitin and proteasome pathways (8 papers) and interferon and immune responses (6 papers). Daichao Xu is often cited by papers focused on Cell death mechanisms and regulation (9 papers), Ubiquitin and proteasome pathways (8 papers) and interferon and immune responses (6 papers). Daichao Xu collaborates with scholars based in China, United States and Germany. Daichao Xu's co-authors include Junying Yuan, Bing Shan, Wanzhi Chen, Palak Amin, Lifeng Pan, Kezhou Zhu, Lihui Qian, Chengyu Zou, Wanjin Li and Masanori Naito and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Daichao Xu

33 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A palmitoylation–depalmitoylation relay spatiotemporally controls GSDMD activation in pyroptosis

2024 72 citations Na Zhang, Zhongwen Chen et al. Nature Cell Biology profile →

Peers

Daichao Xu

MB

IMMUN

EPIDE

CR

ONCOL

Sutapa Ray United States

Fabien Gautier France

Johannes Kreuzer United States

Lucia Cilenti United States

Qiujing Yu China

Iphigenia L. Koumenis United States

Christos E. Zois United Kingdom

Petra Obexer Austria

Haocai Chang China

Hang‐zi Chen China

Sutapa Ray United States

Daichao Xu

1.1k ×0.9

MB

360 ×0.7

IMMUN

138 ×0.3

EPIDE

185 ×0.7

CR

419 ×1.9

ONCOL

Citations per year, relative to Daichao Xu Daichao Xu (= 1×) peers Sutapa Ray

Countries citing papers authored by Daichao Xu

Since Specialization

Citations

This map shows the geographic impact of Daichao Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daichao Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daichao Xu more than expected).

Fields of papers citing papers by Daichao Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daichao Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daichao Xu. The network helps show where Daichao Xu may publish in the future.

Co-authorship network of co-authors of Daichao Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Daichao Xu. A scholar is included among the top collaborators of Daichao Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daichao Xu. Daichao Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Liu, Yan, Rui Guo, Houfang Long, et al.. (2025). Aspirin inhibits proteasomal degradation and promotes α-synuclein aggregate clearance through K63 ubiquitination. Nature Communications. 16(1). 1438–1438. 4 indexed citations

2.

Chen, Hongbo, Huijing Zhang, Jianping Liu, et al.. (2025). RIPK1 senses S-adenosylmethionine scarcity to drive cell death and inflammation. Cell Metabolism. 37(8). 1732–1749.e9. 3 indexed citations

3.

Song, Zhenju, Xingxing Xie, Boxin Zhang, et al.. (2025). Innate immune sensing of Z-nucleic acids by ZBP1-RIPK1 axis drives neuroinflammation in Alzheimer’s disease. Immunity. 58(10). 2574–2592.e9. 2 indexed citations

4.

Zhang, Na & Daichao Xu. (2025). Controlling pyroptosis through post-translational modifications of gasdermin D. Developmental Cell. 60(7). 994–1007. 8 indexed citations

5.

Tang, Yubin, Zhenpeng Guo, Ying Li, et al.. (2025). Mechanistic insights into the GEF activity of the human MON1A/CCZ1/C18orf8 complex. Protein & Cell. 16(8). 739–744. 1 indexed citations

6.

Zhang, Na, et al.. (2024). Emerging roles of palmitoylation in pyroptosis. Trends in Cell Biology. 35(6). 500–514. 15 indexed citations

7.

Liu, Yizhi, Shu‐Hua Zhang, Guoliang Wang, et al.. (2024). ZBP1-mediated apoptosis and inflammation exacerbate steatotic liver ischemia/reperfusion injury. Journal of Clinical Investigation. 134(13). 25 indexed citations

8.

Zhang, Na, Jianping Liu, Rui Guo, et al.. (2024). Palmitoylation licenses RIPK1 kinase activity and cytotoxicity in the TNF pathway. Molecular Cell. 84(22). 4419–4435.e10. 16 indexed citations

9.

Zhang, Na, et al.. (2024). A palmitoylation–depalmitoylation relay spatiotemporally controls GSDMD activation in pyroptosis. Nature Cell Biology. 26(5). 757–769. 72 indexed citations breakdown →

10.

Guo, Rui, Jianping Liu, Min Xia, et al.. (2024). Reduction of DHHC5-mediated beclin 1 S-palmitoylation underlies autophagy decline in aging. Nature Structural & Molecular Biology. 31(2). 232–245. 25 indexed citations

11.

Cui, Na, Bing Shan, Qi Sun, et al.. (2024). Defective prelamin A processing promotes unconventional necroptosis driven by nuclear RIPK1. Nature Cell Biology. 26(4). 567–580. 14 indexed citations

12.

Zhang, Na, Jing Xing, Shuhua Zhang, et al.. (2023). UDP-glucuronate metabolism controls RIPK1-driven liver damage in nonalcoholic steatohepatitis. Nature Communications. 14(1). 14 indexed citations

13.

Li, Wanjin, Bing Shan, Chengyu Zou, et al.. (2022). Nuclear RIPK1 promotes chromatin remodeling to mediate inflammatory response. Cell Research. 32(7). 621–637. 29 indexed citations

14.

Zhang, Tao, Kai Wang, Yuanxin Yang, et al.. (2022). SENP1 prevents steatohepatitis by suppressing RIPK1-driven apoptosis and inflammation. Nature Communications. 13(1). 7153–7153. 47 indexed citations

15.

Zhu, Kezhou, Wei Liang, Zaijun Ma, et al.. (2018). Necroptosis promotes cell-autonomous activation of proinflammatory cytokine gene expression. Cell Death and Disease. 9(5). 500–500. 152 indexed citations

16.

Geng, Jiefei, Yasushi Ito, Linyu Shi, et al.. (2017). Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis. Nature Communications. 8(1). 359–359. 239 indexed citations

17.

Xu, Daichao, Jianping Liu, Tao Fu, et al.. (2017). USP25 regulates Wnt signaling by controlling the stability of tankyrases. Genes & Development. 31(10). 1024–1035. 56 indexed citations

18.

Xu, Daichao, Bing Shan, Juan Xiao, et al.. (2016). USP14 regulates autophagy by suppressing K63 ubiquitination of Beclin 1. Genes & Development. 30(15). 1718–1730. 106 indexed citations

19.

Xiao, Juan, Tao Zhang, Daichao Xu, et al.. (2015). FBXL20-mediated Vps34 ubiquitination as a p53 controlled checkpoint in regulating autophagy and receptor degradation. Genes & Development. 29(2). 184–196. 67 indexed citations

20.

Liu, Bin, Yin Zhang, Daichao Xu, & Wanzhi Chen. (2011). Facile synthesis of metal N-heterocyclic carbene complexes. Chemical Communications. 47(10). 2883–2883. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact